Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates

RAKICI, HALİL; Akdogan, REMZİ; BEDIR, RECEP; Copur, AYŞEGÜL; YILMAZ, Arif

doi:10.1111/1751-2980.12171

Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates

Atıf İçin Kopyala

RAKICI H., Akdogan R. A., BEDIR R., Copur A., YILMAZ A.

JOURNAL OF DIGESTIVE DISEASES, cilt.15, sa.9, ss.508-513, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 9
Basım Tarihi: 2014
Doi Numarası: 10.1111/1751-2980.12171
Dergi Adı: JOURNAL OF DIGESTIVE DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.508-513
Anahtar Kelimeler: eradication rate, Helicobacter pylori, moxifloxacin, patients' compliance, resistance, QUADRUPLE THERAPY, 2ND-LINE TREATMENT, RANDOMIZED-TRIAL, METAANALYSIS, PREVALENCE, RESISTANCE, 1ST-LINE, CLARITHROMYCIN, LEVOFLOXACIN, GUIDELINES
Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

ObjectiveTo compare the patients' compliance with and the efficacy of existing treatments for Helicobacter pylori eradication, including moxifloxacin-based triple therapy, sequential treatment and the standard treatment.